Robert Andrade is CHIEF FINANCIAL OFFICER of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 132,591 shares of FENC, which is worth approximately $702,732. The most recent transaction as insider was on Sep 21, 2022, when has been sold 19,052 shares (Common Shares) at a price of $8.54 per share, resulting in proceeds of $162,704. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K
2.41% 3M change
27.16% 12M change
Total Value Held $702,732

Robert Andrade Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 21 2022
SELL
Sale (or disposition) back to the issuer
$162,704 $8.54 p/Share
19,052 Reduced 9.99%
171,721 Common Shares
Sep 21 2022
BUY
Grant, award, or other acquisition
-
37,500 Added 16.43%
190,773 Common Shares
RA

Robert Andrade

CHIEF FINANCIAL OFFICER
Research Triangle Park, NC

Track Institutional and Insider Activities on FENC

Follow FENNEC PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FENC shares.

Notify only if

Insider Trading

Get notified when an Fennec Pharmaceuticals Inc. insider buys or sells FENC shares.

Notify only if

News

Receive news related to FENNEC PHARMACEUTICALS INC.

Track Activities on FENC